Belmont Capital’s Doximity DOCS Stock Holding History

Belmont Capital’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90,000	Closed	-$3.02M	–	134
2022 Q4	$3.02M	Hold	90,000	–	–	3.23%	8
2022 Q3	$2.72M	Hold	90,000	–	–	3.21%	7
2022 Q2	$3.13M	Buy	+90,000	New	+$3.54M	3.8%	5

Other funds holding DOCS

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Belmont Capital's DOCS Position: Q1 2023 in Review

Belmont Capital sold out of Doximity (DOCS) in Q1 2023, closing a stake of 90,000 shares — an estimated $3.02M sold.

Belmont Capital first reported a position in DOCS in Q2 2022 and held it in 3 quarters. The position peaked at $3.13M in Q2 2022. 298 funds tracked by Wall St. Rank hold DOCS as of Q1 2023.

Belmont Capital reported no remaining Doximity position as of Q1 2023 after selling out during the quarter.
Belmont Capital sold 90,000 Doximity shares in Q1 2023, an estimated $3.02M.
Belmont Capital first reported a position in Doximity in Q2 2022 and held it in 3 quarters.
Belmont Capital's Doximity position peaked at $3.13M in Q2 2022.
298 funds tracked by Wall St. Rank held Doximity as of Q1 2023.

Based on Belmont Capital's 13F filing for Q1 2023, filed 9 May 2023.